Literature DB >> 388463

Application of LAL for detection of endotoxin in antibiotic preparations.

S J Harrison, K Tsuji, R M Enzinger.   

Abstract

The Limulus amebocyte lysate (LAL) test has been investigated as an alternative method to the USP pyrogen test for the detection of endotoxin contamination in these antibiotic preparations: clindamycin phosphate, lincomycin hydrochloride, neomycin sulfate, and spectinomycin hydrochloride. The antibiotic preparations were tested at the maximum concentrations that would not inhibit gelation of LAL. The USP pyrogen test was also performed for comparison. The LAL and the USP pyrogen tests correlated extremely well when an acceptance criterion based on the minimum pyrogenic dose (MPD) of endotoxin per human dose of drug was used for the LAL test. Use of this MPD provides a practical and feasible acceptance creiterion for the LAL test and assures that the LAL sensitivity approximates or surpasses that of the USP pyrogen test.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 388463

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  4 in total

1.  Novel endotoxin assay by laser light-scattering particle-counting method.

Authors:  Kotaro Mitsumoto; Katsumi Yabusaki; Koji Kobayashi; Yoshiaki Shirasawa; Toru Obata
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

2.  Use of magnesium to increase sensitivity of Limulus amoebocyte lysate for detection of endotoxin.

Authors:  K Tsuji; K A Steindler
Journal:  Appl Environ Microbiol       Date:  1983-04       Impact factor: 4.792

3.  Limulus amoebocyte lysate assay for detection and quantitation of endotoxin in a small-volume parenteral product.

Authors:  K Tsuji; K A Steindler; S J Harrison
Journal:  Appl Environ Microbiol       Date:  1980-09       Impact factor: 4.792

4.  Automation of the Limulus amoebocyte lysate test by using the Abbott MS-2 microbiology system.

Authors:  J H Jorgensen; G A Alexander
Journal:  Appl Environ Microbiol       Date:  1981-06       Impact factor: 4.792

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.